Children's Hospital Colorado
Elizabeth McFarland, MD
Infectious Disease

Elizabeth McFarland, MD

Medical Director, Pediatric Infectious Disease Outpatient Clinic
Medical Director, Children's Hospital Colorado HIV Program
Interim Section Chief, Pediatric Infectious Diseases

Specialties:
Infectious Disease - Pediatric, Pediatrics
Conditions:
AIDS, HIV Disease, Immunization, Viral Infections, Sexually Transmitted Diseases
See more
specialties:

Infectious Disease - Pediatric, Pediatrics

conditions:

AIDS, HIV Disease, Immunization, Viral Infections, Sexually Transmitted Diseases, Pneumonia, Influenza, Fungal Infections, Bacterial Infections, Fever

Get to know her background

I am interested in pediatric infectious diseases, particularly pediatric and perinatal HIV Infection.

Undergraduate 1981

Northwestern University (IL)

Medical School 1985

Duke University School of Medicine

Internship 1986

University of Colorado (University Hospital) Program

Residency 1988

University of Colorado (University Hospital) Program, Pediatrics

Fellowship 1992

University of Colorado (University Hospital) Program, Pediatric Infectious Diseases

For Patients:
I am studying the maturation of cell-mediated immune responses in both normal and HIV-infected infants, immune responses to HIV vaccines in exposed newborns, the role of cytotoxic T-lymphocytes in the pathogenesis of congenitally acquired HIV infection, pediatric HIV clinical trials of antiretroviral therapy and vaccines, and complications of HIV and treatment. I develop immunology and immune-based therapy research for the National Institutes of Health Pediatric AIDS Clinical Trials Group and have chaired several of their subcommittees, including the Pediatric Immunology Core Laboratory Committee and the Pediatric Cytotoxic T-lymphocyte Working Group. I am a frequently invited speaker at local, national, and international events.
For Referring Providers:
Dr. McFarland is studying the maturation of cell-mediated immune responses in both normal and HIV-infected infants, immune responses to HIV vaccines in exposed newborns, the role of cytotoxic T-lymphocytes in the pathogenesis of congenitally acquired HIV infection, pediatric HIV clinical trials of antiretroviral therapy and vaccines, and complications of HIV and treatment. Dr. McFarland develops immunology and immune-based therapy research for the National Institutes of Health Pediatric AIDS Clinical Trials Group and has chaired several of their subcommittees, including the Pediatric Immunology Core Laboratory Committee and the Pediatric Cytotoxic T-lymphocyte Working Group. She is a frequently invited speaker at local, national, and international events.

Medical Director, Pediatric Infectious Disease Outpatient Clinic

Medical Director, Children's Hospital Colorado HIV Program

Interim Section Chief, Pediatric Infectious Diseases

PRODWEBSERVER1